Answers are grounded in this paper and cite their sources.
Extracorporeal shockwave therapy as a solitary treatment during the competitive season has no benefit over placebo treatment in the management of actively competing jumping athletes with patellar tendinopathy who have symptoms for less than 12 months.
No takes yet. Share an insight, caveat, or question.
Zwerver et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: